Polku Therapeutics Oy

Polku Therapeutics Oy

This company develops small molecule therapies targeting neurodegenerative diseases for patients with conditions such as dementia, Parkinson's and traumatic brain injury.

Polku Therapeutics

This company develops small-molecule drugs to treat neurodegenerative disorders such as Parkinson's and Alzheimer's disease for patients and pharmaceutical partners.

NeurOdys Therapeutics

This biotechnology company develops small molecule therapies for patients with neurodegenerative conditions such as Alzheimer's and Parkinson's diseases.

Therapeutics Neurodegenerative diseases

This company develops diagnostic tools and therapeutics for patients with neurodegenerative diseases including Alzheimer's and progressive supranuclear palsy.

Yumanity Therapeutics

This company develops small molecule drugs to treat neurodegenerative diseases for patients with conditions such as Parkinson's disease and amyotrophic lateral sclerosis.

Muna Therapeutics

This biopharmaceutical company develops small-molecule therapeutics to treat neurodegenerative diseases, such as Alzheimer's and Parkinson's, for patients and healthcare providers.

CuraSen Therapeutics

This biopharmaceutical company develops small molecule drugs to treat patients with neurodegenerative disorders, such as Parkinson's and Alzheimer's disease.

Asceneuron

The company develops oral small molecule therapies for neurodegenerative diseases including Alzheimer's and Parkinson's to treat patients suffering from chronic neurologic disorders.